Literature DB >> 18043444

Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection.

Beena Puthothu1, Marcus Krueger, Johannes Forster, Jessica Heinze, Markus Weckmann, Andrea Heinzmann.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of bronchiolitis in infants. During the course of RSV infection, predominant T helper cell (TH) 2 response is associated with disease progression, whereas predominant TH1 reaction provides convalescence. Interleukin (IL)-18 plays an important role in adjusting the TH1/TH2 immune response to viral infections. Thus, we tested the hypothesis that polymorphisms in IL-18 were associated with severe RSV-associated diseases.
METHODS: We chose to study the promotor polymorphisms -607A/C (rs1946518) and -137G/C (rs187238), the 2 exon polymorphisms 113T/G (rs360718) and 127C/T (rs360717), and 2 intron polymorphisms 5304A/G (rs795467) and 133G/C (rs360721) within the IL-18 gene. Genotyping was performed on 154 children with severe RSV infection as defined by strict clinical criteria and on 270 controls. Statistical analyses of single polymorphisms made use of the Armitage's trend test, haplotypes were calculated with FASTEHPLUS and FAMHAP.
RESULTS: -133G/C showed association with severe RSV infection (P = 0.043). The association was further supported by haplotype analyses with all 6 polymorphisms (P < 0.00001 for association with RSV).
CONCLUSIONS: This study indicates possible involvement of IL-18 in the determination of severe RSV-associated diseases. Defining the genetic basis of RSV bronchiolitis might help us in identifying new drug targets for a more specific therapy. In addition, it might enable an early identification of children at risk for RSV bronchiolitis and thus make a selective prevention feasible.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18043444     DOI: 10.1097/INF.0b013e3181453579

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  15 in total

1.  Identification of diagnostic biomarkers for infection in premature neonates.

Authors:  Stephen F Kingsmore; Neil Kennedy; Henry L Halliday; Jennifer C Van Velkinburgh; Shengiang Zhong; Vanessa Gabriel; Judith Grant; William D Beavis; Velizar T Tchernev; Lorah Perlee; Serguei Lejnine; Brian Grimwade; Martin Sorette; J David M Edgar
Journal:  Mol Cell Proteomics       Date:  2008-07-13       Impact factor: 5.911

2.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

Review 3.  Evidence for a causal relationship between respiratory syncytial virus infection and asthma.

Authors:  Pingsheng Wu; Tina V Hartert
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

4.  Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.

Authors:  James A Harker; Alexandra Godlee; Jennifer L Wahlsten; Debbie C P Lee; Lucy G Thorne; Devika Sawant; John S Tregoning; Rachel R Caspi; Alexander Bukreyev; Peter L Collins; Peter J M Openshaw
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

5.  Genomewide association analysis of respiratory syncytial virus infection in mice.

Authors:  James M Stark; M Michael Barmada; Abby V Winterberg; Nilanjana Majumber; William J Gibbons; Marilyn A Stark; Maureen A Sartor; Mario Medvedovic; Jay Kolls; Kiflai Bein; Beena Mailaparambil; Marcus Krueger; Andrea Heinzmann; George D Leikauf; Daniel R Prows
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

Review 6.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection.

Authors:  Jonathan M Ciencewicki; Xuting Wang; Jacqui Marzec; M Elina Serra; Douglas A Bell; Fernando P Polack; Steven R Kleeberger
Journal:  FASEB J       Date:  2014-01-13       Impact factor: 5.191

Review 8.  Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.

Authors:  John S Tregoning; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

Review 9.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 10.  Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.